AbbVie Sets Date for Q1 2026 Earnings Conference Call

Apr 29, 2026 12:01 UTC

ABBV

Short term

Pharmaceutical leader AbbVie has announced the schedule for its first-quarter financial review. The company will host a live webcast to discuss its latest earnings results.

Conference call scheduled for April 29, 2026
Start time confirmed for 9:00 AM ET
Focus of the call is Q1 2026 earnings results
Live webcast available via the official investor relations website

AbbVie (ABBV) is scheduled to host a conference call on April 29, 2026, to review its financial performance for the first quarter of the 2026 fiscal year. The call is slated to begin at 9:00 AM ET. This routine corporate event serves as the primary venue for management to present quarterly results and provide operational updates to the investment community. Analysts and shareholders typically monitor these sessions for insights into revenue growth, margin stability, and the progress of the company's drug pipeline. To facilitate transparency and broad access, AbbVie will provide a live webcast of the proceedings. Interested parties can access the event through the company's dedicated investor relations portal. While the announcement of the call time is a standard procedural matter, the subsequent release of actual earnings data and the accompanying management commentary are expected to be the primary drivers of price action for ABBV shares.